InvestorsHub Logo
Followers 4
Posts 243
Boards Moderated 0
Alias Born 05/31/2008

Re: seeker_of_value post# 54263

Thursday, 09/22/2011 6:38:39 PM

Thursday, September 22, 2011 6:38:39 PM

Post# of 146240
Here is the reply from Seymour:

It's really quite logical. The warrant holders, like many others, have been loyal stockholders since the very beginning. The difference between them and people who bought on the open market is that they tied up large amounts of money (up to $500K) for a year and did so when there was a very small difference between the stock price and the offering price. And they did this years ago when we weren't nearly as far along as we are now. Many of these original investors doubled down when we needed more money and they're still holding onto all of their stock. People who bought on the open market had the ability to quickly get out if they felt the need to do so. These warrant holders were tied up for a year (since changed to 6 months)


We may need a small amount of money in the future in order to bring more drugs into the FDA. I can go to these people. They're not the typical sleazy Wall Street financial people who short your stock when you're in discussions with them about raising additional capital. I get at least one offer a day from people who want to give us money. I've turned down everyone.


Some of the holders may never exercise their warrants. If they do, they have to hold the restricted stock for 6 months. Also, the number of warrants is small compared to the total number of shares currently out there.


So, as far as I'm concerned, all of the benefit accrues to the Company, we've remained loyal to those investors who remained loyal to us, there's minimal dilution if and when they exercise and we have a loyal financing source in people who don't play the Wall Street games. What could be better than that?


Make sense?


Sincerely,


PS You have my permission to post this reply


EUGENE SEYMOUR, MD, MPH
Chief Executive Officer
NANOVIRICIDES, INC
Nanotechnology-based targeted anti-viral therapeutics

http://www.nanoviricides.com
eugene@nanoviricides.com
310-486-5677
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News